INSP — Inspire Medical Systems Balance Sheet
0.000.00%
Last trade - 00:00
- $6.35bn
- $5.91bn
- $624.80m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 149 | 234 | 214 | 451 | 460 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 13.1 | 25.1 | 34.2 | 61.2 | 89.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 171 | 270 | 269 | 530 | 594 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.96 | 11.1 | 16.4 | 24.1 | 62.7 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 181 | 281 | 295 | 565 | 677 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 16.9 | 20.7 | 41.3 | 61.2 | 78.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 41.4 | 51.4 | 66 | 68.9 | 104 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 140 | 230 | 229 | 496 | 573 |
Total Liabilities & Shareholders' Equity | 181 | 281 | 295 | 565 | 677 |
Total Common Shares Outstanding |